Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 29, 2007. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons regarding the company's ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The material change reported is a specific share transfer event:
- Date of Transaction: January 26, 2007
- Entity: Abacus (GSK) Trustees Limited (trustee of the GlaxoSmithKline Employee Trust).
- Action: Transferred 10,000 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Notification Date: The company was advised of these transactions on January 29, 2007.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are interested in the shares held in the GSK Trust in the same capacity as other employees or former employees.
Investor Verification Points
- Verify the impact of the 10,000 share transfer on the total outstanding share count and dilution metrics.
- Confirm the specific terms of the SmithKline Beecham Employee Share Option Plan 1991 regarding vesting and exercise conditions.
- Review the full list of directors and their specific holdings within the GSK Trust to assess potential conflicts of interest.